China's Fosun Pharma Aims At RMB 3-5 Billion Profits In Drug Production, Sales
This article was originally published in PharmAsia News
Executive Summary
China's Fosun Pharma will aim for RMB 3-5 billion ($463-$772 million) in profits from its drug sale, drug manufacturing and medical services businesses, said the company's chairman Chen Qiyu